Translate

Universal Biosensors Inc (UBI) - Product Pipeline Analysis, 2017 Update

"Universal Biosensors Inc (UBI) - Product Pipeline Analysis, 2017 Update" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect.

Description-

Summary

Universal Biosensors Inc (UBI) is a medical diagnostic company. The company researches, develops and manufactures in vitro diagnostic test devices that are used for professional and consumer point-of-care. The company is working with Siemens Healthcare to develop a range of products for the point-of-care coagulation market and will manufacture test strips for these products. UBIs major focus areas include coagulation testing, blood glucose testing and other electromechanical cell based tests. Its in-vitro diagnostic test devices are based on electrochemical cell technology platform. The company manages its research and development, and manufacturing operations through its subsidiary, Universal Biosensors Pty Ltd (UBS) in Melbourne. UBI is headquartered in Melbourne, Victoria, Australia.


This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Universal Biosensors Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Universal Biosensors Inc Company Overview 4
Universal Biosensors Inc Company Snapshot 4
Universal Biosensors Inc Pipeline Products and Ongoing Clinical Trials Overview 4
Universal Biosensors Inc Pipeline Analysis Overview 7
Business Description 7
Universal Biosensors Inc - Key Facts 7
Universal Biosensors Inc - Major Products and Services 8
Universal Biosensors Inc Pipeline Products by Development Stage 9
Universal Biosensors Inc Pipeline Products Overview 11
C-Reactive Protein Test 11
C-Reactive Protein Test Product Overview 11
Diagnostic Assay - Coagulation 12
Diagnostic Assay - Coagulation Product Overview 12
DNA/RNA Blood Glucose Test 13
DNA/RNA Blood Glucose Test Product Overview 13
Handheld POC Coagulation Testing System - Ambulatory Care 14
Handheld POC Coagulation Testing System - Ambulatory Care Product Overview 14
Immunoassay Test - D-Dimer 15
Immunoassay Test - D-Dimer Product Overview 15
PT-INR Testing System - Decentralised And Home Use 16
PT-INR Testing System - Decentralised And Home Use Product Overview 16
Universal Biosensors Inc - Key Competitors 17
Universal Biosensors Inc - Key Employees 18
Universal Biosensors Inc - Key Employee Biographies 19
Universal Biosensors Inc - Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Universal Biosensors Inc, Recent Developments 21
May 08, 2017: Commencement of Xprecia Stride Coagulation Analyser sales activities in the US market 21
Oct 04, 2016: Siemens Receives FDA Clearance of the Xprecia Stride Coagulation Analyzer 21
Jun 30, 2016: UBI appoints Craig Coleman as Non-Executive Director 22
Apr 21, 2016: Universal Biosensors Reports Q1 2016 Results 22
Apr 01, 2016: Universal Biosensors Update 22
Mar 02, 2016: Universal Biosensors Appoints David Hoey as Non-Executive Director 23
Feb 19, 2016: Universal Biosensors Announces Retirement of CEO Paul Wright 23
Oct 15, 2015: Development Update: UBI PT-INR Testing System for decentralised and home use 24
Jul 23, 2015: Half Yearly Report and SEC Form 10Q for Q2 2015 24
May 13, 2015: Siemens Healthcare Diagnostics launches Xprecia Stride Coagulation Analyzer 25
Appendix 26
Methodology 26
About GlobalData 28
Contact Us 28
Disclaimer 28


Comments

Post a Comment